How is safety of dermatology drugs assessed: trials, registries, and spontaneous reporting-Reference-Cited by-同舟云学术

How is safety of dermatology drugs assessed: trials, registries, and spontaneous reporting

Published:2020-03-31 Issue:4 Volume:19 Page:449-457
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Asfour Leila¹^ORCID,Yiu Zenas Z.N.¹^ORCID,Warren Richard B.¹

Affiliation:

1. Dermatology Centre, Salford Royal NHS Foundation Trust, the University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2020.1746267

Reference91 articles.

1. A Seat at the Big Table: Expanding the Role of Dermatology at the World Health Organization and Beyond

2. Dermatology in primary care: Prevalence and patient disposition

3. The burden of skin diseases: 2004

4. Psoriasis causes as much disability as other major medical diseases

5. The quality of life in acne: a comparison with general medical conditions using generic questionnaires

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and patient‐reported outcomes from the first 4 years of a Psoriasis Biologics Registry in Singapore;Experimental Dermatology;2023-08-16

2. Shared Decision-making, Therapeutic Choice, and Decisional Regret in Alopecia Areata—Where Narrative Ethics Meets the Unconscious Bias of Clinicians;JAMA Dermatology;2023-04-01

3. Epidemiology of diseases of the skin and subcutaneous tissue and specialized medical care provided in three age groups of the population in 2010–2020 in the Russian Federation;National Health Care (Russia);2022-12-06

4. Postmarket Assessment for Drugs and Biologics Used in Dermatology and Cutaneous Adverse Drug Reactions;Dermatologic Clinics;2022-07